Physicians' Academy for Cardiovascular Education

Integrating icosapent ethyl in preventive strategies: Practical guidance

Listen to the podcast
10' education - June 6, 2023 - Victor Aboyans, MD, PhD – Limoges, France

Video navigation menu

  • Introduction 00:08
  • The need of icosapent ethyl in clinical practice 01:42
  • What do drug agencies and guidelines say about icosapent ethyl? 02:48
  • Clinical trials with mixture of EPA+DHA vs. purified EPA 03:55
  • Implementation of icosapent ethyl in the real-life setting 04:27
  • Safety of icosapent ethyl 05:11
  • Cost-effectiveness of icosapent ethyl 07:34
  • Summary 08:06


Show transcript

Educational information

This lecture by Victor Aboyans was part of the EBAC-accredited symposium " New paradigms in the prevention of ASCVD: The role of EPA and triglycerides" held during ESC Preventive Cardiology in Malaga, Spain.


Victor Aboyans is Professor and Head at the Department of Cardiology, Dupuytren-2 University Hospital, Limoges, France.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Amarin.

Watch other videos in this series Find here the slides of the presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: